Long-term functional outcomes after treatment for localized prostate cancer

4 min


Survival rates after clinically localised prostate cancer are high regardless of the type of treatment chosen, with a median post-cancer life expectancy of about 14 years.

It is therefore important to understand the functional outcomes from various treatments to help inform treatment decisions.

Studies comparing prostatectomy and external-beam radiation therapy with short-term (up to 5 years) follow-up have shown some differences in functional status between treatments but the longer term outcomes had not been investigated before this study.


The purpose of this analysis of a large longitudinal study of prostate cancer outcomes was to compare long-term (15 years follow-up) urinary, bowel, and sexual function after radical prostatectomy with outcomes after external-beam radiation therapy.


The Prostate Cancer Outcomes Study (PCOS) is an American study that enrolled 3533 men in whom prostate cancer had been diagnosed in 1994 or 1995.

The current cohort comprised 1655 men in whom localized prostate cancer had been diagnosed between the ages of 55 and 74 years and who had undergone either surgery (1164 men) or radiotherapy (491 men).

Analysis included men who had completed the 2-year and/or the 5-year survey, as well as the 15-year follow-up. Functional status was assessed at baseline and at 2, 5, and 15 years after diagnosis.

The main analysis was done with multivariable logistic regression (with adjustment for propensity scoring to control for non-random treatment assignment) to compare functional outcomes according to treatment.


Men undergoing prostatectomy were more likely to have urinary incontinence than were those undergoing radiotherapy at 2 years (odds ratio [OR]=6.2; 95% confidence interval [CI]=1.9 to 20.3) and 5 years (OR=5.1; 95% CI=2.3 to 11.4).

However, the odds of urinary incontinence at 15 years (OR=2.3; 95% CI=0.9 to 6.2) was not significantly elevated in the prostatectomy group.

Similarly, although patients undergoing prostatectomy were more likely to have erectile dysfunction at 2 years (OR=3.5; 95% CI=1.9 to 6.2) and 5 years (OR=2.0; 95% CI=1.1 to 3.6), no significant between-group difference was noted at 15 years (OR=0.4; 95% CI=0.1 to 1.2).

Men undergoing prostatectomy were less likely to have bowel urgency at 2 years (OR=0.4; 95% CI=0.2 to 0.7) and 5 years (OR=0.5; 95% CI=0.3 to 0.8), again with no significant between-group difference in the odds of bowel urgency at 15 years (OR=1.0; 95% CI=0.5 to 2.1).


At 15 years, no significant relative differences in disease-specific functional outcomes were observed among men undergoing prostatectomy or radiotherapy. Nonetheless, men treated for localized prostate cancer commonly had declines in all functional domains over 15 years.

Did you find this page helpful?

Information provided on this website is not a substitute for medical advice

Call 000 for emergency services

If you or someone you know needs urgent medical attention.

Call MensLine Australia on 1300 78 99 78 for 24/7 support

MensLine Australia is a telephone and online counselling service for men with emotional health and relationship concerns.

Sign up to our newsletter

We release two monthly newsletters – one written for men, family and friends, and another for health practitioners.

Your preferred mailing list

Your name

Your email

Stay up to date


Healthy Male acknowledges the traditional owners of the land. We pay our respects to elders past, present and future. We are committed to providing respectful, inclusive services and work environments where all individuals feel accepted, safe, affirmed and celebrated.


Healthy Male is funded by the Australian Government Department of Health and Aged Care. This website does not host any form of advertisement. Information provided on this website is not a substitute for medical advice.

Trusted information partner of